Connect Biopharma partners with the Jovante Woods Foundation to enhance asthma education and awareness, aiming to prevent ...

Eli Lilly is increasing Mounjaro's UK price by 170% to match European market levels, with the highest dose now costing £330.

The milestone payment is partially funded through Sarepta’s Arrowhead stock sale as both companies push forward with ...

The Task Force on Safer Childhood Vaccines aims to enhance vaccine safety and innovation, focusing on reducing adverse ...

Challenging six misconceptions that have characterized product strategies in Central and Eastern European markets.

Health plans face challenges in risk arrangements for orphan drugs, but increasing competition may open doors for innovative ...

Seal Rock Therapeutics joins The Michael J. Fox Foundation's LITE program to help advance research and developments in ...

Rob Abbott, CEO, ISPOR, explains how health economics and outcomes research is helping healthcare systems measure the true value of treatments, improve patient outcomes, and address rising drug costs ...

Fate Therapeutics, Generation Bio, and ORIC Pharmaceuticals join a growing list of companies implementing workforce reductions as they restructure operations, extend cash runways, and focus resources ...

Commerce Secretary Howard Lutnick originally stated the investigation should be completed by mid-June. However, a new report ...

Attorney General Paxton argues that the company’s programs and offerings were essentially bribes and resulted in millions in ...

Bayer partners with Kumquat Biosciences to advance a promising Kras G12D cancer treatment, aiming to address critical unmet ...